Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7267 p359
20 September 2003

This article
Reprint
Photocopy


News summary

Related websites
NAO report: "Achieving improvements through clinical governance" (PDF 550K)


Patchy progress on bringing in clinical governance in hospitals, NAO report says

The foundations for clinical governance now exist in nearly all hospital trusts in England but its implementation is patchy, according to a progress report from the National Audit Office (NAO).

The report found that implementation varies “between trusts, within trusts and between components of clinical governance”. It says that there is scope for improvement in developing a coherent approach to quality and in communications between boards of management and clinical teams. It adds that there is also a need to improve the way in which lessons are learnt, both within and between trusts — something the Commission for Health Improvement (CHI) highlighted as one of the most common themes emerging from its inspections of trusts (PJ, 7 December 2002, p797).

Overall, the National Audit Office says that since 1997 the Government’s drive to improve the quality of service to patients within the National Health Service, of which clinical governance forms a central part, “has had many beneficial impacts”. In particular, clinical quality issues have become more mainstream with trust boards realising that they are part of their responsibilities and clinicians beginning to see that clinical concerns can be corporate issues rather than professional and personal ones. There have also been changes towards transparent and collaborative professional cultures with staff attitudes being less defensive and more open, the NAO says.

The report recommends that the NHS Modernisation Agency’s clinical governance support team should be strengthened and ways of sharing best practice between trusts should be explored. CHI and its successor body should ask more questions during its inspections about staff experience of clinical governance, it suggests.

The NAO has restricted its progress report to secondary and tertiary care trusts because, it says, they have had longer to bed in clinical governance systems. Primary care is to be examined later, as are issues surrounding the management of the suspension of clinicians and organisational learning as applied to patient safety.

The NAO report notes that guidance on clinical governance has been issued by the devolved administrations in Scotland and Wales but does not look at how well this guidance has been implemented.


  * PDF files on PJ Online require Acrobat Reader 4 or later

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal